Your institution may have access to this item. Find your institution then sign in to continue.
Title
Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis.
Authors
Goulis, J; Leandro, G; Burroughs, A K
Abstract
Ursodeoxycholic acid (UDCA) is the only approved treatment for primary biliary cirrhosis, but its effect on disease progression and survival is uncertain. The aim of this study was to clarify the efficacy of UDCA in primary biliary cirrhosis.